Tag: Conjunctivitis treatment drug

Alembic Pharma gets USFDA nod for conjunctivitis treatment drug

NEW DELHI: Drug firm Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator for Azelastine Hydrochloride Ophthalmic Solution used for treatment of allergic conjunctivitis. The approved product is therapeutically equivalent to the reference listed drug Optivar Ophthalmic Solution of Mylan Specialty L P. The company has received approval from the […]

Back To Top